Carlsmed Ratios (2024-2026) | CARL

Ratios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin (Quarter) 75.02%72.81%74.66%74.94%73.40%75.93%76.54%77.10%76.78%
EBT Margin (Quarter) -152.89%-162.34%-174.62%-100.57%-93.78%-116.12%-56.84%-101.07%-108.29%
EBIT Margin (Quarter) -103.91%-118.01%-49.93%-56.13%-53.81%-69.11%-61.44%-57.56%-58.27%
EBITDA Margin (Quarter) -103.91%-118.01%-49.93%-56.13%-53.81%-69.11%-61.44%-57.56%-58.27%
Operating Margin (Quarter) -103.91%-118.01%-49.93%-56.13%-53.81%-69.11%-61.44%-57.56%-58.27%
Net Margin (Quarter) -103.22%-127.54%-50.17%-61.96%-56.00%-65.21%-56.80%-53.96%-55.49%
FCF Margin (Quarter) -115.81%-43.41%-80.85%-60.99%-65.92%-31.61%-81.20%-42.16%
Efficiency
Inventory Average (Quarter) 1.20M1.59M1.95M2.17M
Assets Average (Quarter) 94.07M132.49M124.44M118.49M
Invested Capital (Quarter) 15.62M15.62M15.62M15.62M15.62M
Asset Utilization Ratio (Quarter) 0.480.380.450.53
Leverage & Solvency
Interest Coverage Ratio (Quarter) -1.86-2.35-0.39-1.17-1.26-1.27-28.24-1.17-1.07
Debt Ratio (Quarter) 0.300.290.110.120.130.13
Times Interest Earned (Quarter) -1.86-2.35-0.39-1.17-1.26-1.27-28.24-1.17-1.07
Valuation
Enterprise Value (Quarter) -38.15M-44.44M-40.12M-43.43M-33.57M-115.50M-85.89M-73.12M-113.30M
Return Ratios
Return on Sales (Quarter) -0.02%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Capital Employed (Quarter) -31.22%-25.86%-29.75%-36.45%
Return on Assets (Quarter) -0.01%0.00%0.00%-0.01%